Alon Silberman
Impact in
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism
- Biotechnology top 10%
- Cancer Research and Treatments
Papers in
-
- Mitochondrial Function and Pathology 2
- Epigenetics and DNA Methylation 1
- Pluripotent Stem Cells Research 1
-
- Cancer, Hypoxia, and Metabolism 3
- Co-authors
- Ayelet Erez (5 shared papers)Lital N. Adler (2 shared papers)David Dimmock (2 shared papers)Shiran Rabinovich (2 shared papers)Daniel Helbling (2 shared papers)Alona Sarver (1 shared paper)Noa Stettner (1 shared paper)Alexander Brandis (1 shared paper)
- Journals
- Nature Communications (1 paper)Developmental Cell (1 paper)Organic & Biomolecular Chemistry (1 paper)Pain (1 paper)Nature (1 paper)
- Partner nations
- IsraelUnited StatesCanada
In The Last Decade
Alon Silberman
11 papers receiving 517 citations
Peers
Comparison fields: 5 of 68
- Cancer Research 187
- Biotechnology 81
- Toxicology 26
- Biochemistry 51
- Clinical Biochemistry 31
Countries citing papers authored by Alon Silberman
This map shows the geographic impact of Alon Silberman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alon Silberman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alon Silberman more than expected).
Fields of papers citing papers by Alon Silberman
This network shows the impact of papers produced by Alon Silberman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alon Silberman. The network helps show where Alon Silberman may publish in the future.
Co-authors
The 25 scholars most cited alongside Alon Silberman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 269 | |
| 2 | 2018 | 67 | |
| 3 | 2014 | 61 | |
| 4 | 2018 | 30 | |
| 5 | 2019 | 25 | |
| 6 | 2016 | 21 | |
| 7 | 2011 | 21 | |
| 8 | 2021 | 17 | |
| 9 | 2016 | 7 | |
| 10 | 2024 | 2 | |
| 11 | Alleviation of barbiturate inhibition on the oxidative activity of submitochondrial particles by alkali. | 1972 | 1 |
About Alon Silberman
Alon Silberman is a scholar working on Molecular Biology, Cancer Research, Organic Chemistry, Toxicology and Surgery, having authored 11 papers that have together received 521 indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (3 papers), Mitochondrial Function and Pathology (2 papers), Organoselenium and organotellurium chemistry (2 papers), Click Chemistry and Applications (1 paper), Epigenetics and DNA Methylation (1 paper), Enzyme Structure and Function (1 paper), Pluripotent Stem Cells Research (1 paper) and Inflammatory mediators and NSAID effects (1 paper). The work is most often cited by research in Cancer Research (187 citations), Biotechnology (81 citations), Toxicology (26 citations), Biochemistry (51 citations) and Clinical Biochemistry (31 citations). Alon Silberman has collaborated with scholars based in Israel, United States and Canada. Frequent co-authors include Ayelet Erez, Lital N. Adler, David Dimmock, Shiran Rabinovich, Daniel Helbling, Alona Sarver, Noa Stettner, Alexander Brandis, Keren Yizhak and Sandesh C.S. Nagamani. Their work appears in journals such as Nature Communications, Developmental Cell, Organic & Biomolecular Chemistry, Pain and Nature.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.